Open AccessLong-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report
Author(s) -
Kristen J Stefanski,
Julia S. Anixt,
Goodman P,
Katherine Bowers,
Wendy Leisenring,
K. Scott Baker,
Karen Burns,
Rebecca M. Howell,
Stella M. Davies,
Leslie L. Robison,
Gregory T. Armstrong,
Kevin R. Krull,
Christopher J. Recklitis
Publication year - 2020
Publication title -
journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djaa102
Subject(s) - medicine , psychosocial , neurocognitive , quality of life (healthcare) , relative risk , confidence interval , pediatrics , psychiatry , cognition , nursing
Survivors of childhood acute myeloid leukemia (AML) are vulnerable to medical late effects of treatment; however, less is known about their psychosocial outcomes. This study evaluated neurocognitive and psychosocial outcomes in long-term AML survivors treated with bone marrow transplantation (BMT) or intensive chemotherapy (IC) without BMT.